showed a trendP < 0.05
However, in the total patient group and the Phaco-GATT group, MD at 6 and 12 months showed a trend toward progression compared to baseline ( P < 0.05).
However, in the total patient group and the Phaco-GATT group, MD at 6 and 12 months showed a trend toward progression compared to baseline ( P < 0.05).
However, this difference of complete success rates (χ2 = 1.446, P = 0.226) and qualified success rates (χ2 = 0.609, P = 0.435) did not reach statistical significance.